GL1X · GenesisL1 explorer

MolNFT v1 · #84150 · protein

Catalytic domain of mouse 2',3'-cyclic nucleotide 3'- phosphodiesterase, with mutation H230S, crystallized with NADP

3ZBR · 2', 3'-cyclic-nucleotide 3'-phosphodiesterase: “Catalytic domain of mouse 2',3'-cyclic nucleotide 3'- phosphodiesterase, with mutation H230S, crystallized…”. X-ray diffraction, 1 ligand (NAP), 3 pockets (best druggability 0.66).…

PDB
3ZBR
Type
protein
Length
426 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
2', 3'-cyclic-nucleotide 3'-phosphodiesterase
EC
3.1.4.37
UniProt
P16330
Ligands
NAP
Pockets
3 · best druggability 0.66

Structure

x-ray diffraction · 2 distinct chains · 31% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A2', 3'-cyclic-nucleotide 3'-phosphodiesterase (EC 3.1.4.37)protein21532% helix, 30% strandP16330
B2', 3'-cyclic-nucleotide 3'-phosphodiesterase (EC 3.1.4.37)protein21129% helix, 30% strandP16330

Ligands and binding sites

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14970.660.7746NAP
22760.530.7538NAP
32960.530.7533empty

Interfaces

1 interface between chains.

  • A–B · 115 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 3ZBR · Catalytic domain of mouse 2',3'-cyclic nucleotide 3'- phosphodiesterase, with mutation… · the same entry in another collection · chain A against A, TM-score 1.00
  • P16330 · AlphaFold monomer V2.0 prediction for 2',3'-cyclic-nucleotide 3'-phosphodiesterase… · a predicted model of the same protein · chain B against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.